The Risk Evaluation and Mitigation Strategy piece of the FDA Amendments Act of 2007 , aka REMS, was a hot topic at the Task Force meeting last month. While it seems there may be a few wrinkles to work out, our columnist Stephen Lewis thinks it might end up being an area of opportunity for CME providers; others I spoke with weren't so sure we could get past some of the potential conflicts they could involve. Here's a YouTube video he posted recently about REMS:

What do you think? Are the issues insurmountable, or will REMS become part of the CME provider repertoire?

Please or Register to post comments.

Blog Archive

Sponsored Introduction Continue on to (or wait seconds) ×